HIV Drug Approval Highlights SPT Week in Review
Top news of the week from Specialty Pharmacy Times.
5. Cancer Immunotherapy Possible for HIV-Positive Patients
Many immunotherapy clinical trials exclude HIV-positive patients with cancer. Read more.
4. P
harmacy Times Continuing Education Participates in #APharmacistIs Campaign
The #APharmacistIs campaign demonstrates the value of pharmacists in improving the lives of patients. Read more.
3.
Medication Adherence: How Technology Can Help Solve This Billion Dollar Hurdle
Customized technology may help specialty pharmacies drive adherence and patient outcomes. Read more.
2. FDA Kicks Drug Approvals into Overdrive
The FDA granted approval to numerous specialty drugs last week. Read more.
1. First Complete Two-Drug HIV Regimen Receives FDA Approval
Juluca is indicated as a complete therapy for patients with HIV-1. Read more.
